Instructions For Authors
Arrange your manuscript using a word processing program, save as a .doc file, using Microsoft Word.
Cover letter and Signatures: All manuscripts should be accompanied by a cover letter containing the following information:
The title of the paper (Title template)
- A brief description of the significance of the paper to the readers.
- A statement confirming that the material is original, has not already been published, and has not, nor will not, be submitted for publication elsewhere, so long as it is under consideration by this journal.
- Written disclosure of any relationships or support, which might be perceived as constituting a conflict of interest
- Name and signature of corresponding author
There is no limit to the number of authors that may be listed. However, the corresponding author should confirm that the authorship of research publications accurately reflects all authors’ contributions to the work and reporting. All sources of funding along with any conflicts of interest must also be disclosed.
The manuscript can be prepared in Dari language and English abstract using "MS Word".
The text should be 12 point type Times New Roman, fully double-spaced, leaving a margin of 1 inch on all sides. Continuous line numbers (NOT restarting with each page) should be included throughout the manuscript, and pages should be numbered consecutively.
This should include, in the following sequence: the title, a list of all authors with their degrees, the authors institutions- identified by superscripts in numerals. The corresponding author should be denoted by an asterisk, with address, e-mail and phone number in a footnote. The running title should be limited to 40 characters and contain at least 6 key words.
The manuscript title should be as concise as possible. Titles should generally not include abbreviations, and not be longer than 60 characters (including spaces).
This section should detail the problems, experimental approach, major findings and conclusion in one paragraph and should appear on the second page. Avoid abbreviation, diagram and references in the abstract.Keywords: Author(s) must give those key words which repeated frequently and can identify the most important subjects covered by the paper. They must be placed at the end of the abstract.
Author(s) must give those key words which repeated frequently and can identify the most important subjects covered by the paper. They must be placed at the end of the abstract.
The manuscript should include the purpose of the investigation and relating the manuscript to similar previous research. Only information essential to the arguments should be presented.
Materials and Methods:
This section must include specific details about the materials studied, instruments used, specialized chemicals source and related experimental details which allows other research worker to reproduce the results.
Results and Discussions:
The results should be concisely presented. Results and discussion should be separated. The interpreted results should be explained clearly in discussions and should relate them to the existing knowledge in the field as clearly as possible.
Tables should be serially numbered and cited in the text. Each table should be placed on a separate page, at the appropriate point in the text.
Figures should be numbered and cited in the relevant text. All figures should contain a brief legend, with the size being 5x7 inches, and of at least of 500 dpi.
Abbreviations:Abbreviations are commonly overused, bargaining the clarity of manuscripts. Authors are advised to keep abbreviations to a minimum, using them only when they are clearer than their long/full terminology (For example: PCR, DNA), however they should be avoided whenever possible, or when they are non-standard and idiosyncratic. Terms should be written out in full upon first usage, in both the abstract and text, with the abbreviation following in parentheses. After the first usage, the abbreviation must be used consistently.
Drug names:Trademarked names of drugs may not appear in the title but may be used in conjunction with the generic name when the drug is first mentioned in the abstract, and again when first mentioned in the text. Thereafter, use only the generic name.
Names of organisms:Genus and species should be italicized. After the first usage the genus should be abbreviated with a single letter (For example: E. coli). For different species, within a genus, the genus should be fully written out upon first usage of each.
Acknowledgement (if any):This section can be kept at the end of the manuscript before reference section. This section can be used to acknowledge the help of those who do not qualify for authorship or to acknowledge funding, donated resources or significant contribution to the research.
Ethical Approvals:Researches involving human subjects will only be published if such study has been shown in full accordance with ethical principles, including the World Medical Association Declaration of Helsinki (version 2008) and the other requirements, if any, of the country where the research has been carried out. Manuscripts must be complemented by a statement that the experiments were conducted in awareness and written consent of each subject. A statement regarding the fact that the study has been independently reviewed and approved by an ethical board should also be included. Editors reserve the right to reject papers if there are doubts as to whether appropriate procedures have been used.
References:References to the literature cited for the manuscript should be numbered in order of appearance in the manuscript and cited in the text with superscript numbers, that appear after closing punctuation. The reference formatting of this journal is: Vancouver style.
In the reference list, the first 6 authors should be listed. If there are more than 6 authors it should be followed by "et al." The journal names, which appear in the reference list, should use the abbreviated form of the journal, as in PubMed.
Examples of references:
-Hanprasertpong J, Geater A, Jiamset I, Padungkul L, Hirunkajonpan P, Songhong N. Fear of cancer recurrence and its predictors among cervical cancer survivors. J Gynecol Oncol 2017;28:e72.
-Rujirojindakul P, Liabsuetrakul T, McNeil E, Chanchayanon T, Wasinwong W, Oofuvong M, et al. Safety and efficacy of intensive intraoperative glycaemic control in cardiopulmonary bypass surgery: a randomised trial. Acta Anaesthesiol Scand 2014;58:588-96.
- Fealy S, Sperliny JW, Warren RF, Criag EV. Shoulder anthroplasty: complex issues in the primary and revision setting. New York: Thieme; 2008.
- Waltzman SB, Shapiro WH. Cochlear implants in adults. In: Valente M, Hosfond-Dunn H, Roeser RJ, editors. Audiology treatment. 2nd ed. New York: Thieme; 2008;p.361-9.
4. Journal article on the Internet
- Sanders GD, Bayourni AM, Holodnity M, Owens DK. Cost-effectiveness of HIV screening in patients older than 55 year of age. Ann Intern Med [serial on the Internet]. 2008 Jun [cited 2008 Oct 7]; 148(12). Available from: https://www.annals.org/ cgi/reprint/148/12/889.pdf
5. Monograph on the Internet
- Field MJ, Behrman RE. Where children die: improving palliative and end-of- life case for children and their families [monograph on the Internet]. Washington: National Academy Press; 2003 [cited 2008 Sep 26]. Available from: https://nap.edu/openbookphp? record_id=10390&page=1
6. Homepage/Web site
- Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [cited 2008 Oct 3]. Available from: https://www.cancer-pain.org/